查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1621574

尿道感染檢測市場：按適應症、檢測套組、檢測項目、最終用戶分類 - 全球預測 2025-2030

Urinary Tract Infection Testing Market by Indication (Cystitis, Pyelonephritis, Urethritis), Test Kits (Home Test Kits, Laboratory Test Kits), Tests, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

尿道感染檢測市場2023年估值為14億美元，預計到2024年將達到14.7億美元，複合年成長率為4.75%，到2030年將達到19.4億美元。

尿道感染(UTI) 檢測市場包括用於識別泌尿器官系統感染疾病（包括膀胱、腎臟、輸尿管和尿道）的各種診斷工具和程序。尿道結石檢測的必要性源自於疾病的流行，尤其是在女性、老年人和患有糖尿病和脊髓損傷等某些危險因子的人中。應用包括就地檢驗、家庭檢測套組和基於實驗室的診斷，重點是細菌鑑定和抗生素敏感性測試。典型的最終用戶包括醫院、診斷實驗室、研究機構和家庭醫療保健環境。市場成長受到尿道結石結石增加、快速檢測技術進步以及對非侵入性和準確診斷方法不斷成長的需求等因素的影響。我們最新的市場發展包括開發基於人工智慧的診斷工具、將物聯網整合到家庭檢測套組中，以及擴展到醫療需求未滿足的新興市場。為了利用這些機會，公司應專注於聯合研究和合作夥伴關係，以加強其技術並擴大其地理覆蓋範圍。然而，與先進診斷系統相關的限制，例如高成本以及影響治療通訊協定的假陰性和假陽性的可能性，為市場成長帶來了挑戰。監管障礙和臨床檢驗的需求也構成了重大挑戰。業務成長的創新領域包括開發具有成本效益的攜帶式診斷設備、增強微生物培養技術以及擴大病原體的基因識別。儘管市場競爭激烈且分散，但整合遠端醫療進行個人化醫療和遠距離診斷仍有巨大潛力。對快速生物標記識別和抗藥性模式追蹤的持續研究至關重要。企業應優先考慮研發投資和策略夥伴關係關係，以推動創新，應對複雜的市場環境，並滿足醫療保健提供者和患者不斷變化的需求。

主要市場統計
基準年[2023] 14億美元
預測年份 [2024] 14.7億美元
預測年份 [2030] 19.4億美元
複合年成長率（%） 4.75%

市場動態：揭示快速發展的尿道感染感染檢測市場的關鍵市場洞察

供需的動態交互作用正在改變尿道感染檢測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球尿道感染增加
    • 抗生素過度使用和抗藥性增加導致複雜的尿道感染
  • 市場限制因素
    • 尿道感染檢測解決方案產品回想問題
  • 市場機會
    • 不斷開發新的影像技術和檢測設備
    • 政府積極推動快速診斷普及
  • 市場挑戰
    • 與尿道感染相關的社會恥辱

波特五力：駕馭尿道感染感染檢測市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解尿道感染檢測市場的外部影響

外部宏觀環境因素在塑造尿道感染檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解尿道感染檢測市場的競爭狀況

對尿道感染感染檢測市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣尿道感染檢測市場供應商績效評估

FPNV 定位矩陣是評估尿道感染檢測市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了尿道感染檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對尿道感染感染檢測市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球尿道感染發生率增加
      • 抗生素過度使用和抗藥性增加導致複雜的尿道感染
    • 抑制因素
      • 尿道感染檢測解決方案產品回想問題
    • 機會
      • 加大新成像技術和檢測設備的開發力度
      • 政府為提高快速診斷所採取的有利舉措
    • 任務
      • 關於尿道感染的社會恥辱
  • 市場區隔分析
    • 檢測：增加藥敏試驗的使用以避免處方抗生素
    • 最終用戶：在診斷實驗室進行尿道感染感染檢測以檢測細菌是否存在的巨大潛力
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章尿道感染檢測市場（依適應症）

  • 膀胱炎
  • 腎盂腎炎
  • 尿道炎
  • 陰道炎

第7章尿道感染檢測市場檢測試劑套件

  • 家庭檢測套組
  • 臨床檢測套組

第8章尿道感染感染檢測市場按檢測

  • 藥敏試驗
  • 尿液檢查
  • 尿液培養

第9章尿道感染感染檢測市場：依最終用戶分類

  • 診斷實驗室
  • 醫院
  • 腎臟病門診

第10章美洲尿道感染檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太尿道感染檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲尿道感染檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • PathogenDx 用於尿道感染檢測的生態高效 D3 陣列平台方法
    • Vivoo推出智慧家庭測試解決方案，推進泌尿道感染診斷
    • 由德州大學德克薩斯分校的研究人員開發的新型診斷感測器
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Accelerate Diagnostics, Inc.
  • ACON Laboratories, Inc.
  • Beckman Coulter, Inc. by Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Cardinal Health Inc.
  • Chungdo Pharm Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Genetworx, LLC
  • Module Innovations Pvt. Ltd.
  • Piramal Pharma Limited
  • QIAGEN GmbH
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • Stryker Corporation
  • SYSMEX CORPORATION
  • T2 Biosystems, Inc.
  • Thermo Fisher Scientific Inc.
  • Vivosens Inc.
Product Code: MRR-7C50F27396DF

The Urinary Tract Infection Testing Market was valued at USD 1.40 billion in 2023, expected to reach USD 1.47 billion in 2024, and is projected to grow at a CAGR of 4.75%, to USD 1.94 billion by 2030.

The urinary tract infection (UTI) testing market encompasses various diagnostic tools and procedures used to identify infections in the urinary system, including the bladder, kidneys, ureters, and urethra. The necessity for UTI testing is driven by the prevalence of the condition, particularly among women, the elderly, and those with certain risk factors such as diabetes or spinal cord injuries. Applications include point-of-care testing, home testing kits, and laboratory-based diagnostics, with a focus on bacteria identification and antibiotic susceptibility testing. Key end-users include hospitals, diagnostic laboratories, research institutes, and home healthcare settings. Market growth is influenced by factors such as increasing UTI incidences, advancements in rapid testing technologies, and a growing demand for non-invasive and accurate diagnostic methods. Latest opportunities include the development of AI-based diagnostic tools, integration of IoT in home testing kits, and expansion in emerging markets with high unmet medical needs. Companies should focus on collaborations and partnerships for technology enhancement and geographic expansion to leverage these opportunities. However, market growth is challenged by limitations such as high costs associated with advanced diagnostic systems and the potential for false-negative or false-positive outcomes, which can affect treatment protocols. Regulatory hurdles and the need for clinical validation also pose significant challenges. For business growth, areas of innovation include developing cost-effective and portable diagnostic devices, enhancing microbial culture techniques, and expanding the genetic identification of pathogens. The market is competitive and fragmented, with significant potential in personalized medicine and the integration of telemedicine for remote diagnosis. Continued research into rapid biomarker identification and resistance pattern tracking will be pivotal. Businesses should prioritize investment in R&D and strategic partnerships to navigate this complex market landscape, fostering innovations that meet the evolving needs of healthcare providers and patients alike.

KEY MARKET STATISTICS
Base Year [2023] USD 1.40 billion
Estimated Year [2024] USD 1.47 billion
Forecast Year [2030] USD 1.94 billion
CAGR (%) 4.75%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Urinary Tract Infection Testing Market

The Urinary Tract Infection Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of urinary tract infections worldwide
    • Complicated UTIs due to a rise in excessive use of antibiotics and drug resistance
  • Market Restraints
    • Product recall issues with the urinary tract infection testing solutions
  • Market Opportunities
    • Rising development of new imaging technologies and testing devices
    • Favorable initiatives by the government to increase rapid diagnostics
  • Market Challenges
    • Social stigma concerning urinary tract infections

Porter's Five Forces: A Strategic Tool for Navigating the Urinary Tract Infection Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Urinary Tract Infection Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Urinary Tract Infection Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Urinary Tract Infection Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Urinary Tract Infection Testing Market

A detailed market share analysis in the Urinary Tract Infection Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Urinary Tract Infection Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Urinary Tract Infection Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Urinary Tract Infection Testing Market

A strategic analysis of the Urinary Tract Infection Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Urinary Tract Infection Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., ACON Laboratories, Inc., Beckman Coulter, Inc. by Danaher Corporation, Bio-Rad Laboratories, Inc., bioMerieux SA, Cardinal Health Inc., Chungdo Pharm Co., Ltd., F. Hoffmann-La Roche Ltd., Genetworx, LLC, Module Innovations Pvt. Ltd., Piramal Pharma Limited, QIAGEN GmbH, Randox Laboratories Ltd., Siemens Healthineers, Stryker Corporation, SYSMEX CORPORATION, T2 Biosystems, Inc., Thermo Fisher Scientific Inc., and Vivosens Inc..

Market Segmentation & Coverage

This research report categorizes the Urinary Tract Infection Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Cystitis, Pyelonephritis, Urethritis, and Vaginitis.
  • Based on Test Kits, market is studied across Home Test Kits and Laboratory Test Kits.
  • Based on Tests, market is studied across Susceptibility Testing, Urinalysis, and Urine Cultures.
  • Based on End User, market is studied across Diagnostic Laboratories, Hospitals, and Nephropathy Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of urinary tract infections worldwide
      • 5.1.1.2. Complicated UTIs due to a rise in excessive use of antibiotics and drug resistance
    • 5.1.2. Restraints
      • 5.1.2.1. Product recall issues with the urinary tract infection testing solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising development of new imaging technologies and testing devices
      • 5.1.3.2. Favorable initiatives by the government to increase rapid diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Social stigma concerning urinary tract infections
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Tests: Rising usage of susceptibility testing to avoid prescribing antibiotics
    • 5.2.2. End User: High potential for urinary tract infection testing in diagnostic laboratories to detect the presence of bacteria
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Urinary Tract Infection Testing Market, by Indication

  • 6.1. Introduction
  • 6.2. Cystitis
  • 6.3. Pyelonephritis
  • 6.4. Urethritis
  • 6.5. Vaginitis

7. Urinary Tract Infection Testing Market, by Test Kits

  • 7.1. Introduction
  • 7.2. Home Test Kits
  • 7.3. Laboratory Test Kits

8. Urinary Tract Infection Testing Market, by Tests

  • 8.1. Introduction
  • 8.2. Susceptibility Testing
  • 8.3. Urinalysis
  • 8.4. Urine Cultures

9. Urinary Tract Infection Testing Market, by End User

  • 9.1. Introduction
  • 9.2. Diagnostic Laboratories
  • 9.3. Hospitals
  • 9.4. Nephropathy Clinics

10. Americas Urinary Tract Infection Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Urinary Tract Infection Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Urinary Tract Infection Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. PathogenDx's Eco-efficient D3 Array Platform Approach for Urinary Tract Infection Testing
    • 13.3.2. Vivoo Unveils Smart At-Home Testing Solution Advancing UTI Diagnostics
    • 13.3.3. A Novel Diagnostic Sensor Developed by University of Texas at Dallas Researchers
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Accelerate Diagnostics, Inc.
  • 3. ACON Laboratories, Inc.
  • 4. Beckman Coulter, Inc. by Danaher Corporation
  • 5. Bio-Rad Laboratories, Inc.
  • 6. bioMerieux SA
  • 7. Cardinal Health Inc.
  • 8. Chungdo Pharm Co., Ltd.
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. Genetworx, LLC
  • 11. Module Innovations Pvt. Ltd.
  • 12. Piramal Pharma Limited
  • 13. QIAGEN GmbH
  • 14. Randox Laboratories Ltd.
  • 15. Siemens Healthineers
  • 16. Stryker Corporation
  • 17. SYSMEX CORPORATION
  • 18. T2 Biosystems, Inc.
  • 19. Thermo Fisher Scientific Inc.
  • 20. Vivosens Inc.

LIST OF FIGURES

  • FIGURE 1. URINARY TRACT INFECTION TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. URINARY TRACT INFECTION TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. URINARY TRACT INFECTION TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. URINARY TRACT INFECTION TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CYSTITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URETHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY VAGINITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOME TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY LABORATORY TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUSCEPTIBILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINE CULTURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEPHROPATHY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2023